Literature DB >> 28485721

SOST silencing promotes proliferation and invasion and reduces apoptosis of retinoblastoma cells by activating Wnt/β-catenin signaling pathway.

T Wu1, L-N Wang2, D-R Tang1, F-Y Sun1.   

Abstract

This study aimed to investigate the effects of SOST and the Wnt/β-catenin signaling pathway on the proliferation, migration, invasion, and apoptosis of human retinoblastoma cells. Fifty-five retinoblastoma and 21 normal retinal tissue samples were collected as the case group and control group, respectively. HXO-RB44 and SO-RB50 cells were selected and assigned into blank, negative control (NC), siRNA 1, siRNA 2, siRNA 3, IWR-1-endo 1, IWR-1-endo 2 and IWR-1-endo 3 groups. Quantitative real-time polymerase chain reaction (qRT-PCR) was applied to detect the expression of SOST, Wnt-1, and β-catenin in the collected tissue samples. MTT assay, flow cytometry, transwell assay and the starch test were employed to determine the cell proliferation, cell cycle, apoptosis, invasion and migration after transfection. The qRT-PCR and western blotting were also used to detect the mRNA and protein expressions of SOST, Wnt-1, β-catenin, C-myc, Cyclin D1, MMP-2 and MMP-9. The tumor formation in nude mice was conducted to evaluate the effects of SOST on the growth of a transplanted tumor. Compared with normal retinal tissues, the retinoblastoma tissues exhibited a downregulation of SOST but an upregulation of Wnt-1 and β-catenin. The proliferation, invasion and migration of HXO-RB44 and SO-RB50 cells in the SOST-siRNA group were significantly higher than the cells in the blank and NC groups. The expressions of Wnt-1, β-catenin, C-myc, Cyclin D1, MMP-2 and MMP-9 in the three SOST-siRNA groups were elevated, but the SOST decreased when compared with the blank and NC groups. SOST silencing promoted the growth of transplanted tumors in nude mice. These findings indicate that SOST silencing promotes the proliferation, invasion and migration, and decreases the apoptosis of human retinoblastoma cells by activating the Wnt/β-catenin signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28485721     DOI: 10.1038/gt.2017.31

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  26 in total

1.  LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.

Authors:  Y Gong; R B Slee; N Fukai; G Rawadi; S Roman-Roman; A M Reginato; H Wang; T Cundy; F H Glorieux; D Lev; M Zacharin; K Oexle; J Marcelino; W Suwairi; S Heeger; G Sabatakos; S Apte; W N Adkins; J Allgrove; M Arslan-Kirchner; J A Batch; P Beighton; G C Black; R G Boles; L M Boon; C Borrone; H G Brunner; G F Carle; B Dallapiccola; A De Paepe; B Floege; M L Halfhide; B Hall; R C Hennekam; T Hirose; A Jans; H Jüppner; C A Kim; K Keppler-Noreuil; A Kohlschuetter; D LaCombe; M Lambert; E Lemyre; T Letteboer; L Peltonen; R S Ramesar; M Romanengo; H Somer; E Steichen-Gersdorf; B Steinmann; B Sullivan; A Superti-Furga; W Swoboda; M J van den Boogaard; W Van Hul; M Vikkula; M Votruba; B Zabel; T Garcia; R Baron; B R Olsen; M L Warman
Journal:  Cell       Date:  2001-11-16       Impact factor: 41.582

2.  Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling.

Authors:  Xiaofeng Li; Yazhou Zhang; Heeseog Kang; Wenzhong Liu; Peng Liu; Jianghong Zhang; Stephen E Harris; Dianqing Wu
Journal:  J Biol Chem       Date:  2005-03-18       Impact factor: 5.157

Review 3.  The bone marrow metastasis niche in retinoblastoma.

Authors:  Abbas Khosravi; Saeid Shahrabi; Mohammad Shahjahani; Najmaldin Saki
Journal:  Cell Oncol (Dordr)       Date:  2015-06-11       Impact factor: 6.730

4.  Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein.

Authors:  M E Brunkow; J C Gardner; J Van Ness; B W Paeper; B R Kovacevich; S Proll; J E Skonier; L Zhao; P J Sabo; Y Fu; R S Alisch; L Gillett; T Colbert; P Tacconi; D Galas; H Hamersma; P Beighton; J Mulligan
Journal:  Am J Hum Genet       Date:  2001-02-09       Impact factor: 11.025

5.  The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone mass LRP5 mutations.

Authors:  Wendy Balemans; Elke Piters; Erna Cleiren; Minrong Ai; Liesbeth Van Wesenbeeck; Matthew L Warman; Wim Van Hul
Journal:  Calcif Tissue Int       Date:  2008-06       Impact factor: 4.333

6.  Discovery and saturation analysis of cancer genes across 21 tumour types.

Authors:  Michael S Lawrence; Petar Stojanov; Craig H Mermel; James T Robinson; Levi A Garraway; Todd R Golub; Matthew Meyerson; Stacey B Gabriel; Eric S Lander; Gad Getz
Journal:  Nature       Date:  2014-01-05       Impact factor: 49.962

7.  High expression of TAZ indicates a poor prognosis in retinoblastoma.

Authors:  Yiting Zhang; Chunyan Xue; Hongjuan Cui; Zhenping Huang
Journal:  Diagn Pathol       Date:  2015-10-13       Impact factor: 2.644

8.  Inactivation of the retinoblastoma gene yields a mouse model of malignant colorectal cancer.

Authors:  T Parisi; R T Bronson; J A Lees
Journal:  Oncogene       Date:  2015-03-09       Impact factor: 9.867

9.  Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.

Authors:  Baozhi Chen; Michael E Dodge; Wei Tang; Jianming Lu; Zhiqiang Ma; Chih-Wei Fan; Shuguang Wei; Wayne Hao; Jessica Kilgore; Noelle S Williams; Michael G Roth; James F Amatruda; Chuo Chen; Lawrence Lum
Journal:  Nat Chem Biol       Date:  2009-01-04       Impact factor: 15.040

10.  How Accurate is Your Sclerostin Measurement? Comparison Between Three Commercially Available Sclerostin ELISA Kits.

Authors:  Isabelle Piec; Christopher Washbourne; Jonathan Tang; Emily Fisher; Julie Greeves; Sarah Jackson; William D Fraser
Journal:  Calcif Tissue Int       Date:  2016-01-09       Impact factor: 4.333

View more
  7 in total

1.  Tumor suppressive functions of WNT5A in rhabdomyosarcoma.

Authors:  Nada Ragab; Julia Bauer; Anja Uhmann; Alexander Marx; Heidi Hahn; Katja Simon-Keller
Journal:  Int J Oncol       Date:  2022-07-07       Impact factor: 5.884

2.  Sclerostin Suppression Facilitates Uveal Melanoma Progression Through Activating Wnt/β-Catenin Signaling Via Binding to Membrane Receptors LRP5/LRP6.

Authors:  Hanqing Wang; Sidi Zhao; Yang Liu; Fengyuan Sun; Xiaoming Huang; Tong Wu
Journal:  Front Oncol       Date:  2022-06-17       Impact factor: 5.738

Review 3.  The Role of Metalloproteinases and Their Tissue Inhibitors on Ocular Diseases: Focusing on Potential Mechanisms.

Authors:  Miłosz Caban; Katarzyna Owczarek; Urszula Lewandowska
Journal:  Int J Mol Sci       Date:  2022-04-12       Impact factor: 6.208

4.  Cell cycle defects underlie childhood-onset cardiomyopathy associated with Noonan syndrome.

Authors:  Anna B Meier; Sarala Raj Murthi; Hilansi Rawat; Christopher N Toepfer; Gianluca Santamaria; Manuel Schmid; Elisa Mastantuono; Thomas Schwarzmayr; Riccardo Berutti; Julie Cleuziou; Peter Ewert; Agnes Görlach; Karin Klingel; Karl-Ludwig Laugwitz; Christine E Seidman; Jonathan G Seidman; Alessandra Moretti; Cordula M Wolf
Journal:  iScience       Date:  2021-12-09

5.  P38 Mitogen-Activated Protein Kinase Protects Against Retinoblastoma Through Regulating USP22/SIRT1/SOST Axis.

Authors:  Xiaoming Huang; Jianfeng Wan; Fei Liu; Yang Liu; Lina Wang; Sidi Zhao; Tong Wu; Fengyuan Sun
Journal:  Front Oncol       Date:  2022-03-09       Impact factor: 6.244

6.  PRELP Regulates Cell-Cell Adhesion and EMT and Inhibits Retinoblastoma Progression.

Authors:  Jack Hopkins; Ken Asada; Alex Leung; Vasiliki Papadaki; Hongorzul Davaapil; Matthew Morrison; Tomoko Orita; Ryohei Sekido; Hirofumi Kosuge; M Ashwin Reddy; Kazuhiro Kimura; Akihisa Mitani; Kouhei Tsumoto; Ryuji Hamamoto; Mandeep S Sagoo; Shin-Ichi Ohnuma
Journal:  Cancers (Basel)       Date:  2022-10-08       Impact factor: 6.575

7.  LINC01128 regulates the development of osteosarcoma by sponging miR-299-3p to mediate MMP2 expression and activating Wnt/β-catenin signalling pathway.

Authors:  Qiang Yao; Ting Chen
Journal:  J Cell Mol Med       Date:  2020-10-27       Impact factor: 5.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.